Videos / Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice
In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).
Detection, Assessment and Management of Pulmonary Fibrosis
Practical Melanoma Management for GPs
Preventing Renal Failure in Type 2 Diabetes – New Options
Management of Post-Vaccination Reactions
expert
Consultant Paediatric Immunologist & Paediatrician; Perth Children’s Hospital; Head of the Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases